HFA Premium Access

Early experience with sacubitril/valsartan in real life: impact in emergency room and hospital admissions among frequent flyers patients

Congress Session

About the speaker

Doctor Mario Galvan Ruiz

University Hospital Dr Negrin, Las Palmas de Gran Canaria (Spain)
0 follower

25 more presentations in this session

Safety and tolerability of a first in class chymase inhibitor in clinically stable patients with left-ventricular dysfunction after myocardial infarction

Speaker: Doctor M. Senni (Bergamo, IT)

Thumbnail

The relations between pro- and anti-inflammatory cytokines contractile ability of the myocardium in patients with coronary artery disease

Thumbnail

Predictors of galectin-3 in patients with heart failure and reduced ejection fraction

Speaker: Doctor I. Alexanian (Athens, GR)

Thumbnail

The role of Response-to-Diuretic in predicting prognosis in discharged heart failure patients after an acute decompensation.

Speaker: Doctor M. Feola (Mondovi, IT)

Thumbnail

Mobile cardiopaging in toxic cardiomyopathy diagnostics in cancer patients

Speaker: Professor N. Lyamina (Moscow, RU)

Thumbnail

Access the full session

Poster Session 4 - Chronic Heart Failure – Pathophysiology and Mechanisms

Speakers: Doctor M. Galvan Ruiz, Doctor M. Senni, Doctor I. Alexanian, Doctor M. Feola, Professor N. Lyamina
Thumbnail

About the event

Image

Heart Failure 2018 & World Congress on Acute Heart Failure

26 May - 29 May 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk